EURL-ECVAM validates, accepts and recommends deletions for regulatory acceptance of pharmaceuticals, and related products. Includes new submission of tests for phototoxicity, skin corrosivity, inhibition of toxin binding for tetanus vaccines, embryotoxicity assays, using embryonic stem cell, and growth in cell cultures.